Patent disputes on Risperidon between Janssen Korea and Whanin.

Janssen Korea did not accept the lst court judgement on the Riperidon patent disputes allegedly infringed by Whanin, and filed an appeal to the high court right away.

Janssen Korea said "The patent registered by Vita, a Spain company, revealed same in its manufacturing principle and process with Janssen methods, and therefore it was rejected to register in the major advanced countries like ...